M. Matériel, 57 3.1. Population et terrain d'étude, ., p.60

R. Green and S. Flamm, AGA Technical review on the evaluation of liver chemistry tests. gastroenterology, pp.1367-84, 2002.

U. Mathiesen, L. Franzén, A. Frydén, U. Foberg, and G. Bodemar, The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients, European Journal of Gastroenterology & Hepatology, vol.11, issue.4, pp.85-91, 1999.
DOI : 10.1097/00042737-199904000-00025

D. Johnston, special considerations in interpreting Liver function tests, Am Fam Physician, vol.15, issue.598, pp.2223-2253, 1999.

F. Driss, B. Boboc, J. Zarski, M. Cals, S. Pol et al., An Epidemiological and Clinical Study of Transaminase Levels and Hepatitis B Antibodies in 1,100 Blood Donors, Vox Sanguinis, vol.i, issue.1, pp.43-51, 1989.
DOI : 10.1111/j.1423-0410.1989.tb04982.x

T. Dao, I. Lecointe, F. Galateau, F. Freymuth, A. Rideau et al., Apports de la biopsie hépatique et de la sérologie du virus de l'hépatite C au diagnostic d'une augmentation modérée et prolongée des aminotransférases, Gastroenterol Clin Biol, vol.17, pp.37-43, 1993.

L. Kundrotas and D. Clement, Serum alanine aminotransferase (ALT) elevation in asymptomatic US air force basic trainee blood donors, Digestive Diseases and Sciences, vol.9, issue.2, pp.2145-2150, 1993.
DOI : 10.1007/BF01299887

M. Lozano, J. Cid, J. Bedini, R. Mazzara, N. Gimenez et al., Study of serum alanine-aminotransferase levels in blood donors in Spain, Haematologica, vol.83, issue.3, pp.237-246, 1998.

D. Pratt and M. Kaplan, Evaluation of Abnormal Liver-Enzyme Results in Asymptomatic Patients, New England Journal of Medicine, vol.342, issue.17, pp.1266-71, 2000.
DOI : 10.1056/NEJM200004273421707

J. Limdi and G. Hyde, Evaluation of abnormal liver function tests, Postgraduate Medical Journal, vol.79, issue.932, 2003.
DOI : 10.1136/pmj.79.932.307

E. Giannini, R. Testa, and V. Savarino, Liver enzyme alteration: a guide for clinicians, Canadian Medical Association Journal, vol.172, issue.3
DOI : 10.1503/cmaj.1040752

M. Kaplan, Approach to the patient with abnormal liver function tests. up to date. [En ligne] 2010 sep

W. Kim, S. Flamm, D. Bisceglie, A. Bodenheimer, and H. , Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology, pp.1363-701363, 2008.

D. Dufour, J. Lott, F. Nolte, D. Gretch, R. Koff et al., Diagnosis and monitoring of hepatic injury II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring, Clin Chem, issue.12, pp.462050-68, 2000.

A. Agence-nationale-d-'accréditation-et-d-'évaluation-en and . Santé, Actualisation du rapport 1999 sur l'évaluation clinique et économique de l'intérêt du dépistage de l'hémochromatose héréditaire en France. Saint-Denis : ANAES, 2004.

I. Healthcare-katarhealth-roche and . Obepi-roche, Enquête épidémiologique nationale sur le surpoids et l'obésité. www.roche.fr, 2009.

J. Clark, F. Brancati, and A. Diehl, The prevalence and etiology of elevated aminotransferase levels in the United States, The American Journal of Gastroenterology, vol.107, issue.32, pp.960-967, 2003.
DOI : 10.1016/S0002-9343(99)00271-5

J. Herrera, Abnormal liver enzyme levels. the spectrum of causes, pp.113-116, 1993.

D. Dufour, J. Lott, F. Nolte, D. Gretch, R. Koff et al., Diagnosis and monitoring of hepatic injury I. Performance characteristics of laboratory tests, Clin Chem, vol.46, issue.12, pp.2027-2076, 2000.

A. Imbert, M. Colombat, and J. Capron, démarche diagnostique devant une augmentation modérée et prolongée des transaminases, Presse Med, pp.73-81, 2003.

C. Trivaille, P. Chassagne, J. Doucet, M. Perol, I. Landrin et al., ??l??vation des aminotransf??rases, La Revue de M??decine Interne, vol.14, issue.9, pp.832-872, 1993.
DOI : 10.1016/S0248-8663(05)81141-5

I. Leclercq, Y. Horsmans, D. Bruyere, M. Geubel, and A. , Influence of body mass index, sex and age on serum alanine aminotransferase (ALT) level in healthy blood donors, Acta Gastroenterol Belg, vol.62, issue.1, pp.16-20, 1999.

A. Rivera-coll, X. Fuentes-arderiu, and A. Díez-noguera, Circadian Rhythms of Serum Concentrations of 12 Enzymes of Clinical Interest, Chronobiology International, vol.6, issue.3, pp.190-200, 1993.
DOI : 10.3109/07420529009059156

J. Cordoba, O. Riordan, K. Dupuis, J. Borensztajin, J. Blei et al., Diurnal variation of serum alanine transaminase activity in chronic liver disease, Hepatology, vol.560, issue.6, pp.1724-1725, 1999.
DOI : 10.1002/hep.510280640

A. Salvaggio, M. Periti, L. Miano, M. Tavanelli, and D. Marzorati, Body Mass Index and liver enzyme activity in serum, Clin. Chem, vol.37, issue.5, pp.720-723, 1991.

F. Nomura, K. Ohnishi, Y. Satomura, T. Ohtsuki, K. Fukunaga et al., Liver function in moderate obesity--study in 534 moderately obese subjects among 4613 male company employees, Int J Obes, vol.10, issue.5, pp.349-54, 1986.

J. Knight, Liver Function Tests, Journal of Infusion Nursing, vol.28, issue.2
DOI : 10.1097/00129804-200503000-00004

S. Clark, L. Youngman, A. Palmer, S. Parish, R. Peto et al., Stability of plasma analytes after delayed separation of whole blood: implications for epidemiological studies, International Journal of Epidemiology, vol.32, issue.1, pp.125-155, 2003.
DOI : 10.1093/ije/dyg023

J. Aranda-michel and K. Sherman, Tests of the liver: use and misuse, Gastroenterologist, vol.6, issue.1, pp.34-43, 1998.

D. Gopal and H. Rosen, Abnormal findings on liver function tests, Postgraduate Medicine, vol.21, issue.1, pp.100-102, 2000.
DOI : 10.3109/00365528609034632

D. Durand, J. Dupond, M. Pavic, and H. Rousset, Diagnostics difficiles en médecine interne. s.l. : Maloine, pp.513-521, 2008.

D. Pratt and M. Kaplan, Part V: Evaluation of the patient with liver disease. Evaluation of Liver Function

J. Jameson, Harrison's principles of internal medicine 16 ème edition, pp.1813-1819, 2005.

M. Haber, A. West, A. Haber, and A. Reuben, Relationship of aminotransferases to liver histological status in chronic hepatitis C, Am J Gastroenterol, vol.90, pp.1250-1257, 1995.

F. Zanuso, F. Mozzi, S. Milani, D. Conte, M. Colombo et al., Updated definitions of healthy ranges for serum alanine aminotransferase, Ann Intern Med, vol.2, issue.1371, pp.1-10, 2002.

P. Roderick, Liver function tests: defining what's normal, BMJ, vol.328, issue.7446, p.987, 2004.
DOI : 10.1136/bmj.328.7446.987

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC404495

M. Kaplan, Alanine aminotransferase levels: what's normal? Ann Intern Med, pp.49-51, 2002.
DOI : 10.7326/0003-4819-137-1-200207020-00012

F. Layné and D. Guyader, Conduite à tenir devant une cytolyse chronique. Encyclopédie médico-chirurgicale. Hépatologie, 2003.

M. Burke, Liver function: test selection and interpretation of results, Clinics in Laboratory Medicine, vol.22, issue.2, 2002.
DOI : 10.1016/S0272-2712(01)00002-6

A. Bastie and J. P. Capron, étiologies d'une augmentation modérée et prolongée des transaminases: la fin de la "transaminite, Gastroenterol Clin Biol, vol.17, pp.33-36, 1993.

P. Sherwood, I. Lyburn, S. Brown, and S. Ryder, How are abnormal results for liver function tests deal twith in primary care? Audit of yield and impact, BMJ. Feb, vol.3322, issue.7281, pp.276-284, 2001.

P. Quinn and D. Johnston, Detection of chronic liver disease: costs and benefits. Gastroenterologist, pp.58-65, 1997.

R. Kariv, M. Leshno, A. Beth-or, H. Strul, L. Blendis et al., Re-evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large-scale population study, Liver International, vol.37, issue.5, 2006.
DOI : 10.1136/bmj.38050.593634.63

P. Huang, A comprehensive definition for metabolic syndrome Dis Model Mech, pp.5-6231, 2009.

E. Björnsson and P. Angulo, Non-alcoholic fatty liver disease, Scandinavian Journal of Gastroenterology, vol.20, issue.1, pp.1023-1053, 2007.
DOI : 10.1053/j.gastro.2005.04.014

A. Sanyal and . Association, AGA technical review on nonalcoholic fatty liver disease. Gastroenterology, pp.1705-1730, 2002.

L. Castera, Non-invasive diagnosis of steatosis and fibrosis. Diabetes Metab, pp.674-683, 2008.

U. Mathiesen, L. Franzén, H. Aselius, M. Resjö, L. Jacobsson et al., Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis, pp.34516-34538, 2002.

G. Farrell and C. Larter, Nonalcoholic fatty liver disease: From steatosis to cirrhosis, Hepatology, vol.99, issue.S1, pp.99-112, 2006.
DOI : 10.1002/hep.20973

A. Williams and J. Hoofnagle, Ratio of Serum Aspartate to Alanine Aminotransferase in Chronic Hepatitis Relationship to Cirrhosis, Gastroenterology, vol.95, issue.3, pp.734-743, 1988.
DOI : 10.1016/S0016-5085(88)80022-2

M. Ekstedt, L. Franzén, M. Holmqvist, P. Bendtsen, U. Mathiesen et al., Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease, Scandinavian Journal of Gastroenterology, vol.23, issue.3, pp.366-74, 2009.
DOI : 10.1002/hep.1840200611

M. Lazo and J. Clark, The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis, pp.339-50, 2008.

M. Ascha, I. Hanouneh, R. Lopez, T. Tamimi, A. Feldstein et al., The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology, pp.1972-1980, 2010.

R. Rosa, I. Denis, J. , R. P. Lesgourgues, B. Dobrin et al., Paris
DOI : 10.1093/acprof:oso/9780190219628.003.0010

A. Et-santé-en-france, INVS Institut national de Veille Sanitaire. s.l. : INVS, pp.34-35, 2006.

J. Cohen and M. Kaplan, The SGOT/SGPT ratio?An indicator of alcoholic liver disease, Digestive Diseases and Sciences, vol.76, issue.11
DOI : 10.1007/BF01324898

D. Sorbi, J. Boynton, and K. Lindor, The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease, The American Journal of Gastroenterology, vol.21, issue.4, pp.1018-1040, 1999.
DOI : 10.1016/S0002-9270(97)00009-9

I. and I. National-de-veille-sanitaire, Surveillance et prévention des hépatites B et C en France: bilan et perspectives Estimation du nombre annuel de nouvelels infections par les virus de l'hépatite B en France, BEH Bulletin épidémiologique hebdomadaire, pp.20-21, 2004.

P. Deny and F. Zoulim, Hepatitis B virus: From diagnosis to treatment, Pathologie Biologie, vol.58, issue.4, pp.245-53, 2010.
DOI : 10.1016/j.patbio.2010.05.002

C. Chu, Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma, Journal of Gastroenterology and Hepatology, vol.106, issue.5 (Suppl.), pp.25-30, 2000.
DOI : 10.1002/hep.510280130

J. Villeneuve, The natural history of chronic hepatitis B virus infection, Journal of Clinical Virology, vol.34, issue.1, pp.139-181, 2005.
DOI : 10.1016/S1386-6532(05)80024-1

W. Lee, Hepatitis B Virus Infection, New England Journal of Medicine, vol.337, issue.24, pp.1733-1745, 1997.
DOI : 10.1056/NEJM199712113372406

URL : https://hal.archives-ouvertes.fr/hal-01260424

P. Marcellin, T. Asselah, and N. Boyer, Histoire naturelle de l'hépatite C

J. Tsai, J. Jeng, M. Ho, W. Chang, M. Hsieh et al., Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study, British Journal of Cancer, vol.76, issue.7, pp.76968-74, 1997.
DOI : 10.1038/bjc.1997.493

K. Madan, Y. Batra, S. Panda, S. Dattagupta, S. Hazari et al., Role of polymerase chain reaction and liver biopsy in the evaluation of patients with asymptomatic transaminitis: Implications in diagnostic approach, Journal of Gastroenterology and Hepatology, vol.21, issue.11, pp.191291-191300, 2004.
DOI : 10.1016/S0002-9270(99)00507-9

W. Smellie, J. Forth, S. Ryder, M. Galloway, A. Wood et al., Best practice in primary care pathology: review 5, J Clin Pathol, issue.12, pp.1229-1266, 2006.

J. Warszawski, J. Steinmetz, D. Coste, J. Meyer, S. Leiser et al., Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors, J Med Virol, vol.82, issue.4, pp.546-55, 2010.

S. Pol, H??patites virales, EMC - Maladies infectieuses, vol.4, issue.1, pp.61-84, 2011.
DOI : 10.1016/S1166-8598(07)44145-X

D. Antona and . L-'hépatite-b-en-france, aspects épidémiologiques et stratégiques. s.l. : INVS institut national de veille sanitaire, 2006.

M. Wall, J. Baird-lambert, N. Buchanan, and G. Farrell, Liver function tests in persons receiving anticonvulsant medications, Seizure, vol.1, issue.3, pp.187-90, 1992.
DOI : 10.1016/1059-1311(92)90024-U

E. Kuffner, A. Temple, K. Cooper, J. Baggish, and D. Parenti, Retrospective analysis of transient elevations in alanine aminotransferase during long-term treatment with acetaminophen in osteoarthritis clinical trials, Current Medical Research and Opinion, vol.22, issue.11, pp.222137-222185, 2006.
DOI : 10.1185/030079906X148346

A. Tavill, Diagnosis and management of hemochromatosis, Hepatology, vol.33, issue.5, pp.1321-1329, 2001.
DOI : 10.1053/jhep.2001.24783

C. Fowler, Hereditary Hemochromatosis: Pathophysiology, Diagnosis, and Management, Critical Care Nursing Clinics of North America, vol.20, issue.2
DOI : 10.1016/j.ccell.2008.01.003

P. Adams, J. Barton, and . Haemochromatosis, Haemochromatosis, The Lancet, vol.370, issue.9602, pp.1855-60, 2001.
DOI : 10.1016/S0140-6736(07)61782-6

A. Qaseem, M. Aronson, N. Fitterman, V. Snow, K. Weiss et al., Screening for Hereditary Hemochromatosis: A Clinical Practice Guideline from the American College of Physicians, Annals of Internal Medicine, vol.143, issue.7, pp.517-538, 2005.
DOI : 10.7326/0003-4819-143-7-200510040-00010

. Has-haute-autorité-de-santé, Prise en charge de l'hémochromatose liée au gène HFE (hémochromatose de type 1). synthèse des recommandations, 2005.

C. Mclaren, F. Dawkins, I. Kasvosve, R. Acton, J. Barton et al., Comparison of the unsaturated iron-binding capacity with transferrin saturation as a screening test to detect C282Y homozygotes for hemochromatosis in 101,168 participants in the hemochromatosis and iron overload screening (HEIRS) study

P. Brissot, M. Troadec, and O. Loréal, The clinical relevance of new insights in iron transport and metabolism, Curr Hematol Rep, vol.3, issue.2, pp.107-122, 2004.

M. Landoni, B. Cesana, D. Franchis, and R. , Chronic unexplained hypertransaminasemia may be caused by occult celiac disease, Hepatology, vol.29, issue.3, pp.654-661, 1999.

U. Volta, D. Franceschi, L. Lari, F. Molinaro, N. Zoli et al., Coeliac disease hidden by cryptogenic hypertransaminasaemia, The Lancet, vol.352, issue.9121, pp.35226-35235, 1998.
DOI : 10.1016/S0140-6736(97)11222-3

V. De-lédinghen, V. Ratziu, X. Causse, L. Bail, B. Capron et al., Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study, Journal of Hepatology, vol.45, issue.4, pp.592-601, 2006.
DOI : 10.1016/j.jhep.2006.05.008

A. Abdo, J. Meddings, and M. Swain, Liver abnormalities in celiac disease, Clinical Gastroenterology and Hepatology, vol.2, issue.2, pp.107-119, 2004.
DOI : 10.1016/S1542-3565(03)00313-6

D. Volpert, J. Molleston, and D. Perlmutter, ??1-Antitrypsin Deficiency???Associated Liver Disease Progresses Slowly in Some Children, Journal of Pediatric Gastroenterology and Nutrition, vol.31, issue.3, pp.258-63, 2000.
DOI : 10.1097/00005176-200009000-00011

C. Olsson, E. Waldenström, K. Westermark, U. Landegre, and A. Syvänen, Determination of the frequencies of ten allelic variants of the Wilson disease gene (ATP7B), in pooled DNA samples, European Journal of Human Genetics, vol.8, issue.12, pp.933-941, 2000.
DOI : 10.1038/sj.ejhg.5200566

. Has-haute-autorité-de-santé, Maladie de Wilson: protocole national de diagnostic et de soins. s.l. : HAS, 2008.

J. Gollan and T. Gollan, Wilson disease in 1998: genetic, diagnostic and therapeutic aspects, Journal of Hepatology, vol.28, issue.1, pp.28-36, 1998.
DOI : 10.1016/S0168-8278(98)80373-5

J. Frexinos and L. Buscail, Hépato-gastro-entérologie proctologie: Pour le praticien. s.l

D. Gaya, D. Thorburn, K. Oien, A. Morris, and A. Stanley, Hepatic granulomas

P. Kamath, Clinical Approach to the Patient With Abnormal Liver Test Results, Mayo Clinic Proceedings, vol.71, issue.11, pp.1089-94, 1996.
DOI : 10.4065/71.11.1089

I. Hepburn and R. Schade, Pregnancy-Associated Liver Disorders, Dig Dis Sci, 2008.

Y. Bacq, . Foie, and . Grossesse, Association française de formation médicale continue en gastro-entérologie. 21e Journées Nationales de Formation Continue en Hépatogastro-entérologie, pp.29-30

P. Valeix, D. Santos, C. Castetbon, K. Bertrais, S. Cousty et al., Statut thyro??dien et fr??quences des dysthyro??dies chez les adultes inclus dans l?????tude SU.VI.MAX en 1994-1995, Annales d'Endocrinologie, vol.65, issue.6, pp.65477-86, 2004.
DOI : 10.1016/S0003-4266(04)95956-2

M. Huang and Y. Liaw, Clinical associations between thyroid and liver diseases, Journal of Gastroenterology and Hepatology, vol.115, issue.3
DOI : 10.1016/0277-5379(88)90219-2

R. Hultcrantz and N. Gabrielsson, Patients with persistent elevation of aminotransferases: investigation with ultrasonography, radionucleide imaging and liver biopsy, Journal of Internal Medicine, vol.156, issue.1
DOI : 10.1111/j.1365-2796.1993.tb00640.x

S. Daniel, T. Ben-menachem, G. Vasudevan, C. Ma, and M. Blumenkehl, Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients, The American Journal of Gastroenterology, vol.108, issue.10, pp.3010-3014, 1999.
DOI : 10.1053/jhep.1996.v23.pm0008675165

D. Sorbi, D. Mcgill, J. Thistle, T. Therneau, J. Henry et al., An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities, The American Journal of Gastroenterology, vol.15, issue.11
DOI : 10.1053/jhep.1996.v23.pm0008621137

M. Skelly, P. James, and S. Ryder, Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology, Journal of Hepatology, vol.35, issue.2, pp.195-199, 2001.
DOI : 10.1016/S0168-8278(01)00094-0

J. Zarski, Les marqueurs de fibrose. fmcgastro.org, 2003.

M. Lazo, E. Selvin, and J. Clark, Brief Communication: Clinical Implications of Short-Term Variability in Liver Function Test Results, Annals of Internal Medicine, vol.148, issue.5, pp.348-52, 2008.
DOI : 10.7326/0003-4819-148-5-200803040-00005

A. Colli and D. Prati, Drawing Conclusions about Short-Term Variability in Liver Function Test Results, Annals of Internal Medicine, vol.149, issue.2, pp.145-145, 2008.
DOI : 10.7326/0003-4819-149-2-200807150-00017

G. Aragon and Z. Younossi, When and how to evaluate mildly elevated liver enzymes in apparently healthy patients, Cleveland Clinic Journal of Medicine, vol.77, issue.3, pp.195-204, 2010.
DOI : 10.3949/ccjm.77a.09064

K. Musana, S. Yale, and A. Abdulkarim, Tests of Liver Injury, Clinical Medicine & Research, vol.2, issue.2, pp.129-160, 2004.
DOI : 10.3121/cmr.2.2.129

H. Kim, C. Nam, S. Jee, K. Han, D. Oh et al., Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study, BMJ, vol.328, issue.7446, 2004.
DOI : 10.1136/bmj.38050.593634.63

T. Lee, W. Kim, J. Benson, T. Therneau, and L. Melton, Serum aminotransferase activity and mortality risk in a United States community. Hepatology, pp.880-887, 2008.

A. Piton, T. Poynard, F. Imbert-bismut, L. Khalil, J. Delattre et al., Factors associated with serum alanine transaminase activity in healthy subjects: Consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C, Hepatology, vol.21, issue.5, pp.1213-1222, 1998.
DOI : 10.1002/hep.510270505

V. Croquet, E. Vuillemein, C. Ternisien, C. Pillette, F. Oberti et al., Prothrombin index is an indirect marker of serum liver fibrosis, Eur J Gastroenterol Hepatol, vol.14, pp.1-9, 2002.

T. Poynard, P. Bedossa, and P. Opolon, Natural history of liver fibrosis progression in patients with chronic hepatitis C, The Lancet, vol.349, issue.9055, pp.825-857, 1997.
DOI : 10.1016/S0140-6736(96)07642-8

I. and I. National-de-veille-sanitaire, Surveillance et prévention des hépatites B et C en France: bilan et perspectives Évolution du dépistage de l'hépatite C en France à partir des systèmes de surveillance Rena-VHC et des pôles de référence, BEH Bulletin épidémiologique hebdomadaire, vol.2021, pp.199-203, 2000.

A. and A. Nationale, Accréditation et d'Évaluation en Santé, Service des recommandations et références professionnelles Diagnostic et suivi virologiques des hépatites virales (à l'exlusion en

G. Jeanblanc and . Has, Service Evaluation Economique et Santé Publique Note de cadrage: algorithme de dépistage des hépatites B et C. Paris : HAS, novembre, 2009.

C. Tiribelli, Prevalence of and risk factors for hepatic steatosis in Northern Italy, Ann Intern Med, vol.132, issue.1322, pp.112-7112, 2000.

I. , K. , O. , W. Alain, P. Ricordeau et al., Diabète traité en France en 2007: un taux de prévalence proche de 4% et des disparités géographiques croissantes. [éd.] Institut national de veille sanitaire INVS. BEH, Bulletin épidémiologique hebdomadaire, pp.409-422, 2008.

I. and I. National-de-veille-sanitaire, Surveillance de l'hypertension artérielle en France Niveau tensionnel moyen et prévalence de l'hypertension artérielle chez les adultes de 18 à 74 ans, étude ENNS 2006-2007, Bulletin épidémiologique hebdomadaire. INVS, vol.16, pp.49-50, 2008.

J. Cadranel, Statine et Foie. fmcgastro.org. [En ligne, 2007.

A. Aneja, F. El-atat, S. Mcfarlane, and J. Sowers, Hypertension and Obesity, Recent Progress in Hormone Research, vol.59, issue.1, pp.169-205, 2004.
DOI : 10.1210/rp.59.1.169

J. Fan, Impact of non-alcoholic fatty liver disease on accelerated metabolic complications, Journal of Digestive Diseases, vol.15, issue.2, pp.63-70, 2008.
DOI : 10.1111/j.1440-1746.2007.04977.x

V. Ratziu and T. Poynard, Assessing the outcome of nonalcoholic steatohepatitis? It's time to get serious. Hepatology, pp.802-807, 2006.

C. Pillette, V. Croquet, E. Vuillemin, F. Oberti, and P. Calès, Diagnostic précoce et non invasif de la cirrhose du foie, Gastroenterol Clin Biol, vol.23, pp.657-665, 1999.

M. Selzner and P. Clavien, Fatty liver in liver transplantation and surgery. Semin Liver Dis, pp.105-118, 2001.

J. Scoazec, La ponction-biopsie h??patique??: quelle place aujourd???hui dans la prise en charge du patient???, Annales de Pathologie, vol.30, issue.6, pp.464-473, 2010.
DOI : 10.1016/j.annpat.2010.08.026

V. Leroy, Other non-invasive markers of liver fibrosis, Gastroent??rologie Clinique et Biologique, vol.32, issue.6, pp.52-57, 2008.
DOI : 10.1016/S0399-8320(08)73993-9

T. Poynard, First-line assesment of patients with chronic liver disease with non-invasive techniques and without recourse to liver biopsy, J Hepatol, vol.14, 2010.

S. Mcpherson, S. Stewart, E. Henderson, A. Burt, and C. Day, Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut, pp.1265-1274, 2010.

V. Ratziu, L. Martin, L. Fedchuk, and T. Poynard, Can nonalcoholic steatohepatitis be diagnosed without liver biopsy? Biomarkers Med, pp.353-361, 2009.
DOI : 10.2217/bmm.09.36

L. Castera, Le fibroscan; un nouvel outil pour l'évaluation non invasive de la fibrose au cours des maladies chroniques du foie. Hépato-gastro. Mars-Avril, 2007.

L. Adams and P. Angulo, Treatment of non-alcoholic fatty liver disease, Postgraduate Medical Journal, vol.82, issue.967, pp.315-337, 2006.
DOI : 10.1136/pgmj.2005.042200

V. Ratziu and M. Tahiri, Peut-on traiter la stéaothépatite métabolique? http://www.snfge.asso.fr, 2010.